Differential expression of microRNA between triple negative breast cancer patients of African American and European American descent

References

• Ali Ahmed E, Abd El-Basit SA, Mohamed MA, Swellam M. 2020. Clinical role of MiRNA 29a and MiRNA 335 on breast cancer management: their relevance to MMP2 protein level. Arch Physiol Biochem. 1–8. doi:10.1080/13813455.2020.1749085.
   Web of Science ®Google Scholar
• Arner P, Kulyté A. 2015. MicroRNA regulatory networks in human adipose tissue and obesity. Nat Rev Endocrinol. 11:276–2015. doi:10.1038/nrendo.2015.25.
   PubMed Web of Science ®Google Scholar
• Banegas MP, Li CI. 2012. Breast cancer characteristics and outcomes among Hispanic Black and Hispanic White women. Breast Cancer Res Treat. 134:1297–1304. doi:10.1007/s10549-012-2142-1.
   PubMed Web of Science ®Google Scholar
• Baron JA, Cole BF, Sandler RS, Haile RW, Ahnen D, Bresalier R, McKeown-Eyssen G, Summers RW, Rothstein R, Burke CA. 2003. A randomized trial of aspirin to prevent colorectal adenomas. N Engl J Med. 348:891–899. doi:10.1056/NEJMoa021735.
   PubMed Web of Science ®Google Scholar
• Braun CJ, Zhang X, Savelyeva I, Wolff S, Moll UM, Schepeler T, Ørntoft TF, Andersen CL, Dobbelstein M. 2008. p53-Responsive microRNAs 192 and 215 are capable of inducing cell cycle arrest. Cancer Res. 68:10094–10104. doi:10.1158/0008-5472.CAN-08-1569.
   PubMed Web of Science ®Google Scholar
• Carey LA, Perou CM, Livasy CA, Dressler LG, Cowan D, Conway K, Karaca G, Troester MA, Tse CK, Edmiston S. 2006. Race, breast cancer subtypes, and survival in the Carolina breast cancer study. J Am Med Assoc. 295:2492–2502. doi:10.1001/jama.295.21.2492.
   PubMed Web of Science ®Google Scholar
• Castelao J, Yuan J, Gago-Dominguez M, Yu M, Ross R. 2000. Non-steroidal anti-inflammatory drugs and bladder cancer prevention. Br J Cancer. 82:1364–1369. doi:10.1054/bjoc.1999.1106.
   PubMed Web of Science ®Google Scholar
• Chen L, Song Y, Lu Y, Zheng W, Ma W, Zhang C. 2016. miR-335 inhibits cell proliferation, migration and invasion in HeLa cervical cancer cells. Int J Clin Exp Pathol. 9:10351–10362.
   Web of Science ®Google Scholar
• Cui W, Zhang Y, Hu N, Shan C, Zhang S, Zhang W, Zhang X, Ye L. 2010. miRNA-520b and miR-520e sensitize breast cancer cells to complement attack via directly targeting 3′ UTR of CD46. Cancer Biol Ther. 10:232–241. doi:10.4161/cbt.10.3.12277.
   PubMed Web of Science ®Google Scholar
• Danforth Jr DN Jr. 2013. Disparities in breast cancer outcomes between Caucasian and African American women: a model for describing the relationship of biological and nonbiological factors. Breast Cancer Res. 15:1–15. doi:10.1186/bcr3429.
   Web of Science ®Google Scholar
• Deshmukh SK, Srivastava SK, Tyagi N, Ahmad A, Singh AP, Ghadhban AA, Dyess DL, Carter JE, Dugger K, Singh S. 2017. Emerging evidence for the role of differential tumor microenvironment in breast cancer racial disparity: a closer look at the surroundings. Carcinogenesis. 38:757–765. doi:10.1093/carcin/bgx037.
   PubMed Web of Science ®Google Scholar
• Dietze EC, Sistrunk C, Miranda-Carboni G, O’regan R, Seewaldt VL. 2015. Triple-negative breast cancer in African American women: disparities versus biology. Nat Rev Cancer. 15:248–254. doi:10.1038/nrc3896.
   PubMed Web of Science ®Google Scholar
• Dong Y, Liu Y, Jiang A, Li R, Yin M, Wang Y. 2018. MicroRNA-335 suppresses the proliferation, migration, and invasion of breast cancer cells by targeting EphA4. Mol Cell Biochem. 439:95–104. doi:10.1007/s11010-017-3139-1.
   PubMed Web of Science ®Google Scholar
• Du X, Fan W, Chen Y. 2018. microRNA-520f inhibits hepatocellular carcinoma cell proliferation and invasion by targeting TM4SF1. Gene. 657:30–38. doi:10.1016/j.gene.2018.03.003.
   PubMed Web of Science ®Google Scholar
• Esau C, Davis S, Murray SF, Yu XX, Pandey SK, Pear M, Watts L, Booten SL, Graham M, McKay R. 2006. miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting. Cell Metab. 3:87–98. doi:10.1016/j.cmet.2006.01.005.
   PubMed Web of Science ®Google Scholar
• Gao X-L, Li J-Q, Dong Y-T, Cheng E-J, Gong J-N, Qin Y-L, Huang Y-Q, Yang J-J, Wang S-J, An D-D. 2018. Upregulation of microRNA-335-5p reduces inflammatory responses by inhibiting FASN through the activation of AMPK/ULK1 signaling pathway in a septic mouse model. Cytokine. 110:466–478. doi:10.1016/j.cyto.2018.05.016.
   PubMed Web of Science ®Google Scholar
• Garza-Morales R, Gonzalez-Ramos R, Chiba A, de Oca-Luna RM, McNally L, McMasters K, Gomez-Gutierrez J. 2018. Temozolomide enhances triple-negative breast cancer virotherapy in vitro. Cancers. 10:144. doi:10.3390/cancers10050144.
   Web of Science ®Google Scholar
• Garzon R, Pichiorri F, Palumbo T, Iuliano R, Cimmino A, Aqeilan R, Volinia S, Bhatt D, Alder H, Marcucci G. 2006. MicroRNA fingerprints during human megakaryocytopoiesis. Proc Natl Acad Sci USA. 103:5078–5083. doi:10.1073/pnas.0600587103.
   PubMed Web of Science ®Google Scholar
• Greten FR, Grivennikov SI. 2019. Inflammation and cancer: triggers, mechanisms, and consequences. Immunity. 51:27–41. doi:10.1016/j.immuni.2019.06.025.
   PubMed Web of Science ®Google Scholar
• Grivennikov SI, Greten FR, Karin M. 2010. Immunity, inflammation, and cancer. Cell. 140:883–899. doi:10.1016/j.cell.2010.01.025.
   PubMed Web of Science ®Google Scholar
• Guo L, Zhang Y, Zhang L, Huang F, Li J, Wang S. 2016. MicroRNAs, TGF-β signaling, and the inflammatory microenvironment in cancer. Tumor Biol. 37:115–125. doi:10.1007/s13277-015-4374-2.
   PubMedGoogle Scholar
• Hackler L, Masuda T, Oliver VF, Merbs SL, Zack DJ. 2012. Use of laser capture microdissection for analysis of retinal mRNA/miRNA expression and DNA methylation. Retinal development. Springer: Totowa, NJ; p. 289–304.
   Google Scholar
• Han Y, Moore JX, Langston M, Fuzzell L, Khan S, Lewis MW, Colditz GA, Liu Y. 2019. Do breast quadrants explain racial disparities in breast cancer outcomes? Cancer Causes Contr. 30:1171–1182. doi:10.1007/s10552-019-01222-x.
   PubMed Web of Science ®Google Scholar
• Heyn H, Engelmann M, Schreek S, Ahrens P, Lehmann U, Kreipe H, Schlegelberger B, Beger C. 2011. MicroRNA miR‐335 is crucial for the BRCA1 regulatory cascade in breast cancer development. Int J Cancer. 129:2797–2806. doi:10.1002/ijc.25962.
   PubMed Web of Science ®Google Scholar
• Howlader N, Altekruse SF, Li CI, Chen VW, Clarke CA, Ries LA, Cronin KA. 2014. US incidence of breast cancer subtypes defined by joint hormone receptor and HER2 status. J Natl Cancer Inst. 106:dju055. doi:10.1093/jnci/dju055.
   PubMedGoogle Scholar
• Huang J, Egger M, Grizzle W, McNally L. 2013a. MicroRNA-100 regulates IGF1-receptor expression in metastatic pancreatic cancer cells. Biotech Histochem. 88:397–402. doi:10.3109/10520295.2012.762460.
   PubMed Web of Science ®Google Scholar
• Huang X, Taeb S, Jahangiri S, Emmenegger U, Tran E, Bruce J, Mesci A, Korpela E, Vesprini D, Wong CS. 2013b. miRNA-95 mediates radio-resistance in tumors by targeting the sphingolipid phosphatase SGPP1. Cancer Res. 73:6972–6986. doi:10.1158/0008-5472.CAN-13-1657.
   PubMed Web of Science ®Google Scholar
• Hughes L, Ruth K, Rebbeck TR, Giri VN. 2013. Genetic variation in IL-16 miRNA target site and time to prostate cancer diagnosis in African American men. Prost Cancer Prost Dis. 16:308–314. doi:10.1038/pcan.2013.36.
   PubMed Web of Science ®Google Scholar
• Iorio MV, Ferracin M, Liu C-G, Veronese A, Spizzo R, Sabbioni S, Magri E, Pedriali M, Fabbri M, Campiglio M. 2005. MicroRNA gene expression deregulation in human breast cancer. Cancer Res. 65:7065–7070. doi:10.1158/0008-5472.CAN-05-1783.
   PubMed Web of Science ®Google Scholar
• Keklikoglou I, Koerner C, Schmidt C, Zhang J, Heckmann D, Shavinskaya A, Allgayer H, Gückel B, Fehm T, Schneeweiss A. 2012. MicroRNA-520/373 family functions as a tumor suppressor in estrogen receptor negative breast cancer by targeting NF-κB and TGF-β signaling pathways. Oncogene. 31:4150–4163. doi:10.1038/onc.2011.571.
   PubMed Web of Science ®Google Scholar
• Kerr EH, Frederick PJ, Egger ME, Stockard CR, Sellers J, DellaManna D, Oelschlager DK, Amm HM, Eltoum I-E, Straughn JM, Buchsbaum DJ, Grizzle WE, McNally LR. 2013. Lung resistance-related protein (LRP) expression in malignant ascitic cells as a prognostic marker for advanced ovarian serous carcinoma. Ann Surg Onc. 20:3059–3065. doi:10.1245/s10434-013-2878-9.
   PubMed Web of Science ®Google Scholar
• Lee S, Rauch J, Kolch W. 2020. Targeting MAPK signaling in cancer: mechanisms of drug resistance and sensitivity. Int J Mol Sci. 21:1102–1130. doi:10.3390/ijms21031102.
   PubMed Web of Science ®Google Scholar
• Li E, Ji P, Ouyang N, Zhang Y, Wang XY, Rubin DC, Davidson NO, Bergamaschi R, Shroyer KR, Burke S. 2014. Differential expression of miRNAs in colon cancer between African and Caucasian Americans: implications for cancer racial health disparities. Int J Oncol. 45:587–594. doi:10.3892/ijo.2014.2469.
   PubMed Web of Science ®Google Scholar
• Li J, Smyth P, Flavin R, Cahill S, Denning K, Aherne S, Guenther SM, O’Leary JJ, Sheils O. 2007. Comparison of miRNA expression patterns using total RNA extracted from matched samples of formalin-fixed paraffin-embedded (FFPE) cells and snap frozen cells. BMC Biotechnol. 7:1–6. doi:10.1186/1472-6750-7-36.
   PubMed Web of Science ®Google Scholar
• Liang Z, Bian X, Shim H. 2014. Inhibition of breast cancer metastasis with microRNA-302a by downregulation of CXCR4 expression. Breast Cancer Res Treat. 146:535–542. doi:10.1007/s10549-014-3053-0.
   PubMed Web of Science ®Google Scholar
• Lim LP, Lau NC, Garrett-Engele P, Grimson A, Schelter JM, Castle J, Bartel DP, Linsley PS, Johnson JM. 2005. Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature. 433:769–773. doi:10.1038/nature03315.
   PubMed Web of Science ®Google Scholar
• Liu X, Wang F, Tian L, Wang T, Zhang W, Li B, Bai Y-A. 2016. MicroRNA-520b affects the proliferation of human glioblastoma cells by directly targeting cyclin D1. Tumor Biol. 37:7921–7928. doi:10.1007/s13277-015-4666-6.
   PubMedGoogle Scholar
• Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA. 2005. MicroRNA expression profiles classify human cancers. Nature. 435:834–838. doi:10.1038/nature03702.
   PubMed Web of Science ®Google Scholar
• Lu K, Liu C, Tao T, Zhang X, Zhang L, Sun C, Wang Y, Chen S, Xu B, Chen M. 2015. MicroRNA- 19a regulates proliferation and apoptosis of castration-resistant prostate cancer cells by targeting BTG1. FEBS Lett. 589:1485–1490. doi:10.1016/j.febslet.2015.04.037.
   PubMed Web of Science ®Google Scholar
• Ma W, Ma C, Li X, Zhang Y. 2016. Examining the effect of gene reduction in miR-95 and enhanced radiosensitivity in non-small cell lung cancer. Cancer Gene Ther. 23:66–71. doi:10.1038/cgt.2016.2.
   PubMed Web of Science ®Google Scholar
• MacCuaig WM, Fouts BL, McNally MW, Grizzle WE, Chuong P, Samykutty A, Mukherjee P, Li M, Jasinski JB, Behkam B, McNally LR. 2021. Active targeting significantly outperforms nanoparticle size in facilitating tumor-specific uptake in orthotopic pancreatic cancer. ACS Appl Mater Interf. 13:49614–49630. doi:10.1021/acsami.1c09379.
   PubMed Web of Science ®Google Scholar
• MacFarlane L-A, Murphy P. 2010. MicroRNA: biogenesis, function and role in cancer. Curr Genom. 11:537–561. doi:10.2174/138920210793175895.
   PubMed Web of Science ®Google Scholar
• Martin DN, Boersma BJ, Yi M, Reimers M, Howe TM, Yfantis HG, Tsai YC, Williams EH, Lee DH, Stephens RM. 2009. Differences in the tumor microenvironment between African American and European American breast cancer patients. PloS One. 4:e4531–e4531. doi:10.1371/journal.pone.0004531.
   PubMed Web of Science ®Google Scholar
• Masuda N, Ohnishi T, Kawamoto S, Monden M, Okubo K. 1999. Analysis of chemical modification of RNA from formalin-fixed samples and optimization of molecular biology applications for such samples. Nucl Acids Res. 27:4436–4443. doi:10.1093/nar/27.22.4436.
   PubMed Web of Science ®Google Scholar
• McNally LR, Manne U, Grizzle WE. 2013. Post-transcriptional processing of genetic information and its relation to cancer. Biotech Histochem. 88:365–372. doi:10.3109/10520295.2012.730152.
   PubMed Web of Science ®Google Scholar
• Mestdagh P, Feys T, Bernard N, Guenther S, Chen C, Speleman F, Vandesompele J. 2008. High- throughput stem-loop RT-qPCR miRNA expression profiling using minute amounts of input RNA. Nucl Acids Res. 36:e143–e143. doi:10.1093/nar/gkn725.
   PubMed Web of Science ®Google Scholar
• Miller B, Chalfant H, Thomas A, Wellberg E, Henson C, McNally MW, Grizzle WE, Jain A, McNally LR. 2021. Diabetes, obesity, and inflammation: impact on clinical and radiographic features of breast cancer. Int J Mol Sci. 22:2757. doi:10.3390/ijms22052757.
   PubMed Web of Science ®Google Scholar
• Morris GJ, Mitchell EP. 2008. Higher incidence of aggressive breast cancers in African American women: a review. J Natl Med Assoc. 100:698–702. doi:10.1016/S0027-9684(15)31344-4.
   PubMed Web of Science ®Google Scholar
• Naguibneva I, Ameyar-Zazoua M, Polesskaya A, Ait-Si-Ali S, Groisman R, Souidi M, Cuvellier S, Harel-Bellan A. 2006. The microRNA miR-181 targets the homeobox protein Hox-A11 during mammalian myoblast differentiation. Nat Cell Biol. 8:278–284. doi:10.1038/ncb1373.
   PubMed Web of Science ®Google Scholar
• Okabe Y, Medzhitov R. 2016. Tissue biology perspective on macrophages. Nat Immunol. 17:9–17. doi:10.1038/ni.3320.
   PubMed Web of Science ®Google Scholar
• Ooi SL, Martinez ME, Li CI. 2011. Disparities in breast cancer characteristics and outcomes by race/ethnicity. Breast Cancer Res Treat. 127:729–738. doi:10.1007/s10549-010-1191-6.
   PubMed Web of Science ®Google Scholar
• Ritter B, Greten FR. 2019. Modulating inflammation for cancer therapy. J Exp Med. 216:1234–1243. doi:10.1084/jem.20181739.
   PubMed Web of Science ®Google Scholar
• Shi XB, Tepper CG, White RW. 2008. MicroRNAs and prostate cancer. J Cell Mol Med. 12:1456–1465. doi:10.1111/j.1582-4934.2008.00420.x.
   PubMed Web of Science ®Google Scholar
• Sochor M, Basova P, Pesta M, Dusilkova N, Bartos J, Burda P, Pospisil V, Stopka T. 2014. Oncogenic microRNAs: miR-155, miR-19a, miR-181b, and miR-24 enable monitoring of early breast cancer in serum. BioMed Cent Cancer. 14:448.
   Google Scholar
• Song Q, Song J, Wang Q, Ma Y, Sun N, Ma J, Chen Q, Xia G, Huo Y, Yang L. 2016. miR‐548d‐ 3p/TP 53 BP 2 axis regulates the proliferation and apoptosis of breast cancer cells. Cancer Med. 5:315–324. doi:10.1002/cam4.567.
   PubMed Web of Science ®Google Scholar
• Sonkoly E, Pivarcsi A. 2009. MicroRNAs in inflammation. Int Rev Immunol. 28:535–561. doi:10.3109/08830180903208303.
   PubMed Web of Science ®Google Scholar
• Srinivasan M, Sedmak D, Jewell S. 2002. Effect of fixatives and tissue processing on the content and integrity of nucleic acids. Am J Pathol. 161:1961–1971. doi:10.1016/S0002-9440(10)64472-0.
   PubMed Web of Science ®Google Scholar
• Theodore SC, Davis M, Zhao F, Wang H, Chen D, Rhim J, Dean-Colomb W, Turner T, Ji W, Zeng G. 2014. MicroRNA profiling of novel African American and Caucasian prostate cancer cell lines reveals a reciprocal regulatory relationship of miR-152 and DNA methyltranferase 1. Oncotarget. 5:3512–3525. doi:10.18632/oncotarget.1953.
   PubMedGoogle Scholar
• Theodore SC, Rhim JS, Turner T, Yates C. 2010. MiRNA 26a expression in a novel panel of African American prostate cancer cell lines. Ethn Dis. 20:96–100.
   Web of Science ®Google Scholar
• Thomas A, Rhoads A, Pinkerton E, Schroeder MC, Conway KM, Hundley WG, McNally LR, Oleson J, Lynch CF, Romitti PA. 2019. Incidence and survival among young women with stage I–III breast cancer: SEER 2000–2015. J Natl Cancer Inst Cancer Spect. 3: pkz040.
   Google Scholar
• Todoric J, Antonucci L, Karin M. 2016. Targeting inflammation in cancer prevention and therapy. Cancer Prevent Res. 9:895–905. doi:10.1158/1940-6207.CAPR-16-0209.
   PubMed Web of Science ®Google Scholar
• Trinchieri G. 2012. Cancer and inflammation: an old intuition with rapidly evolving new concepts. Ann Rev Immunol. 30:677–706. doi:10.1146/annurev-immunol-020711-075008.
   PubMed Web of Science ®Google Scholar
• van Kampen JG, van Hooij O, Jansen CF, Smit FP, van Noort PI, Schultz I, Schaapveld RQ, Schalken JA, Verhaegh GW. 2017. miRNA-520f reverses epithelial-to-mesenchymal transition by targeting ADAM9 and TGFBR2. Cancer Res. 77:2008–2017. doi:10.1158/0008-5472.CAN-16-2609.
   PubMedGoogle Scholar
• Wallace TA, Prueitt RL, Yi M, Howe TM, Gillespie JW, Yfantis HG, Stephens RM, Caporaso NE, Loffredo CA, Ambs S. 2008. Tumor immunobiological differences in prostate cancer between African American and European American men. Cancer Res. 68:927–936. doi:10.1158/0008-5472.CAN-07-2608.
   PubMed Web of Science ®Google Scholar
• Wang B-D, Ceniccola K, Yang Q, Andrawis R, Patel V, Ji Y, Rhim J, Olender J, Popratiloff A, Latham P. 2015. Identification and functional validation of reciprocal microRNA-mRNA pairings in African American prostate cancer disparities. Clin Cancer Res. 21:4970–4984. doi:10.1158/1078-0432.CCR-14-1566.
   PubMed Web of Science ®Google Scholar
• Wang F, Li T, Zhang B, Li H, Wu Q, Yang L, Nie Y, Wu K, Shi Y, Fan D. 2013. MicroRNA-19a/b regulates multidrug resistance in human gastric cancer cells by targeting PTEN. Biochem Biophys Res Commun. 434:688–694. doi:10.1016/j.bbrc.2013.04.010.
   PubMed Web of Science ®Google Scholar
• Wang S, Wang L, Zhu T, Gao X, Li J, Wu Y, Zhu H. 2010. Improvement of tissue preparation for laser capture microdissection: application for cell type-specific miRNA expression profiling in colorectal tumors. BioMed Cent Genom. 11:163.
   Google Scholar
• Wei Z-J, Tao M-L, Zhang W, Han G-D, Zhu Z-C, Miao Z-G, Li J-Y, Qiao Z-B. 2015. Up- regulation of microRNA-302a inhibited the proliferation and invasion of colorectal cancer cells by regulation of the MAPK and PI3K/Akt signaling pathways. Int J Clin Exp Pathol. 8:4481–4491.
   PubMed Web of Science ®Google Scholar
• Wu F, Zikusoka M, Trindade A, Dassopoulos T, Harris ML, Bayless TM, Brant SR, Chakravarti S, Kwon JH. 2008. MicroRNAs are differentially expressed in ulcerative colitis and alter expression of macrophage inflammatory peptide-2α. Gastroenterology. 135:1624–1635. doi:10.1053/j.gastro.2008.07.068.
   PubMed Web of Science ®Google Scholar
• Xiao J, Li G, Zhou J, Wang S, Liu D, Shu G, Zhou J, Ren F. 2018. MicroRNA-520b functions as a tumor suppressor in colorectal cancer by inhibiting defective in cullin neddylation 1 domain containing 1 (DCUN1D1). Oncol Res Preclin Clin Cancer Ther. 26:593–604.
   Google Scholar
• Xu X-M, Wang X-B, Chen M-M, Liu T, Li Y-X, Jia W-H, Liu M, Li X, Tang H. 2012. MicroRNA- 19a and-19b regulate cervical carcinoma cell proliferation and invasion by targeting CUL5. Cancer Lett. 322:148–158. doi:10.1016/j.canlet.2012.02.038.
   PubMed Web of Science ®Google Scholar
• Yan-Chun L, Hong-Mei Y, Zhi-Hong C, Qing H, Yan-Hong Z, Ji-Fang W. 2017. MicroRNA-192-5p promote the proliferation and metastasis of hepatocellular carcinoma cell by targeting SEMA3A. Appl Immunohistochem Mol Morphol. 25:251–260. doi:10.1097/PAI.0000000000000296.
   PubMedGoogle Scholar
• Yang X-D, Xu X-H, Zhang S-Y, Wu Y, Xing C-G, Ru G, Xu H-T, Cao J-P. 2015. Role of miR-100 in the radio resistance of colorectal cancer cells. Am J Cancer Res. 5:545–559.
   PubMed Web of Science ®Google Scholar
• Zhang G-M, Bao C-Y, Wan F-N, Cao D-L, Qin X-J, Zhang H-L, Zhu Y, Dai B, Shi G-H, Ye D-W. 2015. MicroRNA-302a suppresses tumor cell proliferation by inhibiting AKT in prostate cancer. PLoS One. 10:e0124410. doi:10.1371/journal.pone.0124410.
   PubMed Web of Science ®Google Scholar
• Zhang W, Kong G, Zhang J, Wang T, Ye L, Zhang X. 2012. MicroRNA-520b inhibits growth of hepatoma cells by targeting MEKK2 and cyclin D1. PloS One. 7:e31450. doi:10.1371/journal.pone.0031450.
   PubMed Web of Science ®Google Scholar
• Zhao G, Wang T, Huang Q-K, Pu M, Sun W, Zhang Z-C, Ling R, Tao K-S. 2016a. MicroRNA- 548a-5p promotes proliferation and inhibits apoptosis in hepatocellular carcinoma cells by targeting Tg737. World J Gastroenterol. 22:5364–5373. doi:10.3748/wjg.v22.i23.5364.
   PubMed Web of Science ®Google Scholar
• Zhao L, Wang Y, Jiang L, He M, Bai X, Yu L, Wei M. 2016b. MiR-302a/b/c/d cooperatively sensitizes breast cancer cells to adriamycin via suppressing P-glycoprotein (P-gp) by targeting MAP/ERK kinase 1 (MEKK1). J Exp Clin Cancer Res. 35:1–14. doi:10.1186/s13046-016-0300-8.
   PubMed Web of Science ®Google Scholar
• Zhou X, Li X, Ye Y, Zhao K, Zhuang Y, Li Y, Wei Y, Wu M. 2014. MicroRNA-302b augments host defense to bacteria by regulating inflammatory responses via feedback to TLR/IRAK4 circuits. Nat Commun. 5:1–14. doi:10.1038/ncomms4619.
   Web of Science ®Google Scholar
• Zhu L, Chen L, Shi C-M, Xu G-F, Xu -L-L, Zhu -L-L, Guo X-R, Ni Y, Cui Y, Ji C. 2014. MiR-335, an adipogenesis-related microRNA, is involved in adipose tissue inflammation. Cell Biochem Biophys. 68:283–290. doi:10.1007/s12013-013-9708-3.
   PubMed Web of Science ®Google Scholar